- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00497445
The Value of Supervised Exercise Therapy After Invasive Treatment of Peripheral Arterial Disease (NETP-extra)
Additional Exercise Therapy in Patients With Peripheral Arterial Disease: The Value of Supervised Exercise Therapy After Invasive Treatment of Peripheral Arterial Disease.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Treatment of peripheral arterial disease consists of vascular risk factor management and, dependent on the severity of the disease, exercise therapy, and either radiological or surgical intervention. After invasive treatment, many patients keep complaints, or complaints return, despite the fact that the treated segment is still patent.
Supervised exercise therapy (SET) has been proved to be an effective treatment for patients with intermittent claudication, with a significant increase in maximal walking distance. Further, exercise therapy contributes to an improvement in quality of life, a delay in disease progression and an improvement of the vascular risk profile.
Research on SET after an invasive intervention is rare. In one study, the effect of SET after surgical treatment on walking distance was determined. The initial claudication distance increased significantly in the exercise group, compared with surgical treatment alone.
In June 2004, the Network for Exercise Therapy Parkstad (NETP) was implemented in Heerlen and its environs. The physiotherapists of this network provide community based SET according to the protocol of the Royal Dutch Society of Physiotherapy. The web based database, which is a part of the NETP, was retrospectively searched for patients who started SET within 2 months after a radiological or surgical intervention. Seventeen patients fulfilled these criteria, and after 1, 3, 6 and 12 months, there was a significant increase in both initial claudication distance (ICD) and absolute claudication distance (ACD).
The expectation is that SET, immediately offered after an invasive intervention for peripheral arterial disease, influences walking distance and quality of life. Further, a positive influence on vascular risk factors and the frequency of re-interventions is expected.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
PO box 4446
-
Heerlen, PO box 4446, Netherlands
- Atrium Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- PAD stage 2 or 3 according to Fontaine,
- Surgical or radiological intervention indicated
Exclusion Criteria:
- No insurance for physiotherapy,
- Insufficient command of the Dutch language,
- Serious cardiopulmonary limitations (NYHA 3-4,)
- Major amputation,
- Serious co-morbidity prohibiting physical training
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Angioplasty / surgery and exercise therapy
Angioplasty / surgery followed by supervised exercise therapy
|
Percutaneous vascular intervention or surgery for peripheral arterial disease followed by supervised exercise therapy
|
No Intervention: Angioplasty / surgery
Angioplasty / surgery alone
|
Percutaneous vascular intervention or surgery for peripheral arterial disease
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
maximum walking distance
Time Frame: one year
|
one year
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
quality of life fontaine stage ankle brachial index vascular risk factors re-interventions patency mortality.
Time Frame: one year
|
one year
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Joep A. Teijink, PhD, MD, Atrium medical center Parkstad
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 06-P-62
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Peripheral Arterial Disease
-
University of NebraskaNot yet recruitingPeripheral Arterial Disease | Peripheral Vascular Diseases | Peripheral Arterial Occlusive Disease | Peripheral Artery DiseaseUnited States
-
CID S.p.A.Meditrial Europe Ltd.Not yet recruitingPeripheral Arterial Occlusive Disease | Peripheral Artery DiseaseItaly
-
Marissa JarosinskiRecruitingPeripheral Arterial Occlusive Disease | Peripheral Vascular Disease | Peripheral Artery Disease | Clopidogrel, Poor Metabolism of | Artery DiseaseUnited States
-
Stanford UniversityTerminatedPAD - Peripheral Arterial Disease | PVD- Peripheral Vascular DiseaseUnited States
-
Vascuros Medical Pte LtdNovella ClinicalUnknownPeripheral Arterial Occlusive Disease | Peripheral Vascular Disease | Peripheral Artery DiseaseSingapore, Belgium, Germany
-
Western Vascular Institute, IrelandRecruitingPeripheral Arterial Occlusive DiseaseIreland
-
Jena University HospitalAngioDroid s.r.l., Bologna (Italy)CompletedPeripheral Arterial Occlusive DiseaseGermany
-
Seoul National University HospitalAstellas Pharma Korea, Inc.CompletedPeripheral Arterial Occlusive DiseaseKorea, Republic of
-
Heidelberg UniversityTerminatedPeripheral Arterial Occlusive DiseaseGermany
-
Johann Wolfgang Goethe University HospitalSuspendedPeripheral Arterial Occlusive DiseaseGermany
Clinical Trials on Angioplasty / surgery and exercise therapy
-
Vanderbilt UniversityWithdrawnEnd-Stage Renal DiseaseUnited States
-
M.J.W. KoelemaijZonMw: The Netherlands Organisation for Health Research and DevelopmentTerminatedPeripheral Arterial Disease | Intermittent ClaudicationNetherlands
-
Sisli Hamidiye Etfal Training and Research HospitalCompletedLumbar Spinal StenosisTurkey
-
University of NebraskaNational Institute on Aging (NIA); American Heart AssociationCompletedPeripheral Arterial DiseaseUnited States
-
Assiut UniversityUnknownHemodialysis Access Failure
-
Onze Lieve Vrouwe GasthuisCompletedOsteoarthritis, Knee | Meniscus Tear, Tibial
-
Sudhalkar Eye HospitalCompleted
-
Beijing Tiantan HospitalCompleted
-
Hull University Teaching Hospitals NHS TrustUniversity of HullCompletedIntermittent Claudication | Femoropopliteal DiseaseUnited Kingdom
-
Boston Children's HospitalCompleted